A detailed history of Kpp Advisory Services LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Kpp Advisory Services LLC holds 8,281 shares of APLS stock, worth $254,806. This represents 0.06% of its overall portfolio holdings.

Number of Shares
8,281
Previous 11,266 26.5%
Holding current value
$254,806
Previous $432 Million 44.74%
% of portfolio
0.06%
Previous 0.11%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$28.84 - $41.15 $86,087 - $122,832
-2,985 Reduced 26.5%
8,281 $239 Million
Q2 2024

Aug 27, 2024

SELL
$38.07 - $59.71 $4,949 - $7,762
-130 Reduced 1.14%
11,266 $432 Million
Q1 2024

May 14, 2024

BUY
$55.39 - $72.47 $11,078 - $14,494
200 Added 1.79%
11,396 $670 Million
Q4 2023

Feb 14, 2024

BUY
$37.14 - $64.82 $62,209 - $108,573
1,675 Added 17.59%
11,196 $670 Million
Q3 2023

Nov 14, 2023

BUY
$23.65 - $89.22 $225,171 - $849,463
9,521 New
9,521 $362 Million

Others Institutions Holding APLS

About Apellis Pharmaceuticals, Inc.


  • Ticker APLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 109,865,000
  • Market Cap $3.38B
  • Description
  • Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...
More about APLS
Track This Portfolio

Track Kpp Advisory Services LLC Portfolio

Follow Kpp Advisory Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kpp Advisory Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kpp Advisory Services LLC with notifications on news.